Search Within

Alison Moskowitz

Formats
  1. Meeting Abstract (196)
  2. Journal Article (126)
  3. Review (13)
  4. Research Letter (12)
  5. Editorial (5)
  6. Guidelines (4)
  7. Correspondence (2)
  8. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (359)
  2. Department of Medicine (359)
  3. Hematologic Malignancies, Division of (359)
  4. Lymphoma (359)
  5. Population Sciences Research Program (235)
  6. Survivorship Research (149)

More Groups

People
  1. Steven Horwitz (234)
  2. Andrew Zelenetz (130)
  3. Paul Hamlin (119)
  4. Ariela Noy (118)
  5. Anita Kumar (106)
  6. Maria Palomba (103)

More People

Years
  1. 2025 (11)
  2. 2024 (37)
  3. 2023 (37)
  4. 2022 (20)
  5. 2021 (36)
  6. 2020 (30)

More Years

Publications
  1. Blood (150)
  2. Hematological Oncology (23)
  3. Journal of Clinical Oncology (22)
  4. Blood Advances (15)
  5. Leukemia and Lymphoma (15)
  6. Journal of the American Academy of Dermatology (14)

More Publications

Publishers
  1. American Society of Hematology (168)
  2. Wiley Blackwell (31)
  3. American Society of Clinical Oncology (25)
  4. Elsevier Inc. (22)
  5. Taylor & Francis Group (16)
  6. Mosby Elsevier (14)

More Publishers

Results (359)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TP53 mutations identify high-risk peripheral T-cell lymphoma patients treated with CHOP-based chemotherapy
    Meeting Abstract

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Maccaro, C.; Galasso, N.; Sauter, C. S.; Neuman, R.; Khan, N.; Moskowitz, A. J.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience
    Meeting Abstract

    Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Effect of brentuximab vedotin addition to chemotherapy and prognostic factors in patients with relapsed/refractory hodgkin lymphoma: A large multi-trial analysis based on individual patient data
    Meeting Abstract

    Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L. L.; LaCasce, A. S.; Moskowitz, C. H.; Garcia-Sanz, R.; Cole, P. D.; Fuchs, M.; Mueller, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of choice of platinum-based salvage therapy on CNS relapse in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Buege, M. J.; Dao, P.; Dematteo, R. G.; LeVoir, A.; Pak, T.; Batlevi, C. L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • How to choose first salvage therapy in Hodgkin lymphoma: Traditional chemotherapy vs novel agents
    Review

    Driessen, J.; Tonino, S. H.; Moskowitz, A. J.; Kersten, M. J.
    Hematology-American Society of Hematology Education Program (2021)

    Fulltext@MSK | Save
  • Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial
    Journal Article

    Horwitz, S.; Zinzani, P. L.; Bagot, M.; Kim, Y. H.; Moskowitz, A. J.; Porcu, P.; Dwyer, K.; Sun, W.; Herr, F. M.; Scarisbrick, J.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of adult lymphoma-associated hemophagocytic lymphohistiocytosis (HLH)
    Meeting Abstract

    Lee, C. Y.; Wills, B.; Vardhana, S. A.; Moskowitz, A. J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis
    Review

    Stoll, J. R.; Willner, J.; Oh, Y.; Pulitzer, M.; Moskowitz, A.; Horwitz, S.; Myskowski, P.; Noor, S. J.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save